New MDMA Board Chairman Chavez Will Tackle User Fee, GPO Issues
This article was originally published in The Gray Sheet
Executive Summary
Securing adequate funds to implement the device user fee program and monitoring the business practices of group purchasing organizations will remain the top priorities for the Medical Device Manufacturers Association in the coming year, according to outgoing board chairman Paul Touhey
You may also be interested in...
MDMA board of directors
Dynatronics Corp. President and CEO Kelvyn Cullimore, New Enterprise Associates Partner Ryan Drant and Advanced Medical Optics Corporate VP Russell Trenary join Medical Device Manufacturers Association board. Chris Chavez, president and CEO of Advanced Neuromodulation Systems, was elected chairman in June (1"The Gray Sheet" June 9, 2003, p. 5)...
As Casgevy, Lyfgenia Launches Proceed, CRISPR And bluebird bio CEOs Reassure
The CEOs of bluebird bio and CRISPR Therapeutics hope to inspire investor confidence that their gene-based therapies for sickle cell disease and beta thalassemia will be widely reimbursed in the US and EU.